Pages that link to "Q40767295"
Jump to navigation
Jump to search
The following pages link to The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor (Q40767295):
Displaying 14 items.
- Glyphosate toxicity and carcinogenicity: a review of the scientific basis of the European Union assessment and its differences with IARC. (Q34554675) (← links)
- Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target. (Q39309007) (← links)
- In Silico Prediction of Organ Level Toxicity: Linking Chemistry to Adverse Effects (Q39458432) (← links)
- Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes (Q41364504) (← links)
- Crosstalk between Receptor and Non-receptor Mediated Chemical Modes of Action in Rat Livers Converges through a Dysregulated Gene Expression Network at Tumor Suppressor Tp53. (Q45738215) (← links)
- Adverse outcome pathways: From research to regulation scientific workshop report. (Q53175763) (← links)
- Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors (Q57178915) (← links)
- Integrating data gap filling techniques: A case study predicting TEFs for neurotoxicity TEQs to facilitate the hazard assessment of polychlorinated biphenyls (Q57805649) (← links)
- Risk for animal and human health related to the presence of dioxins and dioxin‐like PCBs in feed and food (Q62086878) (← links)
- Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation (Q64096098) (← links)
- An Adverse Outcome Pathway (AOP) for forestomach tumors induced by non-genotoxic initiating events (Q88442577) (← links)
- Dose-Related Severity Sequence, and Risk-Based Integration, of Chemically Induced Health Effects (Q89088599) (← links)
- Comparison of Gene Expression Responses in the Small Intestine of Mice Following Exposure to 3 Carcinogens Using the S1500+ Gene Set Informs a Potential Common Adverse Outcome Pathway (Q90313042) (← links)
- Chronic inflammation, Adverse Outcome Pathways, and risk assessment: A diagrammatic exposition (Q93208761) (← links)